TABLE I

Specific Lysis by HLA-A2-restricted c~ H-Y CTL
Materials and Methods Peripheral blood lymphocytes were obtained from a female patient with aplastic anemia, in partial remission (HLA phenotype A2, Bw44, B40, Cw3, Cw5, Dw4, Dw6, DR4, DRw6) (5). The lymphocytes were separated from her peripheral blood by Ficoll-Isopaque (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N J) -gradient eentrifugation. We have shown previously (9) that her cells (after a 6-d in vitro sensitization against the irradiated PBL from an HLA-A, -B, -C, and -DR-identical but mixed lymphocyte reaction [MLR] -positive unrelated male donor) were able to lyse cells from HLA-A2 positive male donors but not from other donors. These HLA-A2 restricted anti-H-Y CTL were, on the day of assay, mixed with the target cells in different effector/target cell ratios. The target cells were 51Cr labeled or nonlabeled (i.e., cold inhibitor cells) PHA-stimulated lymphoblasts.
The indirect immunofluorescence method used for detection of HLA-A2 restricted anti-H-Y antibody and the cell-mediated lympholysis (CML) assay were performed as described previously (7, 8) . Continuous growing of the 6-d specific cytotoxic effector cells was carried out, and cytotoxic T cell lines were obtained with specific HLA-A2-restricted anti-H-Y cytotoxic activity stronger than that seen with the bulk cultures (10) .
Results
The results of testing the HLA-A2-restricted anti-H-Y CTL against a panel of phytohemagglutinin (PHA) blast target cells from males and females (HLA-A2 positive or negative) are summarized in Table I . They show that, with the exception of cells from the male donor M7, all male target cells that expressed HLA-A2 and H-Y antigens were lysed by CTL.
In cold target inhibition experiments, the lysis of 51Cr-labeled HLA-A2-positive male target cells by the HLA-A2-restricted H-Y-specific CTL was inhibited by a panel of unlabeled cold inhibitor cells (Fig. 1) . No significant inhibition ofcytotoxicity was obtained by the addition of cold M7 inhibitor cells, whereas normal HLA-A2-positive male cells strongly inhibited cytotoxicity. The level of inhibition obtained with cold M7 cells is comparable to the level of inhibition obtained by the addition of HLA-A2-negative male cold target cells.
These experiments with CTL generated in bulk culture were repeated using a cytotoxic T cell line established from this same patient. The results (Table II) Results are the means of three experiments. * The presence of lympholytic antibodies, directed against a subset of the B cells from male HLA-A2 positive males, have been described earlier (7). It was found that complement-dependent cytolytic antibodies react with part of the B cells stained with anti-Ig fluorescein isothiocyanate (6) . The monocytes were differentiated from the B cells by treatment of the blood with latex. § Donors 1-4 carry the serologically defined HLA-A2 antigen.
(designated serum R) was virtually indistinguishable from that of the anti-H-Y CTL obtained from the same patient. Serum R specifically detects an antigen that consists of components contributed by both HLA-A2 and H-Y. Cells from donor M7 were tested for reactivity with serum R to determine if such an HLA-A2 plus H-Y association could be demonstrated on the cell surface. The results in Table III demonstrate that the HLA-A2 plus H-Y-specific antiserum did react with M7 cells, and that the level of cytotoxicity was comparable to that obtained with control normal HLA-A2 positive male cells. The antibody activity appeared to be directed mainly against B cells, which is consistent with our earlier observations (7). These results indicate that the association of HLA-A2 and H-Y detected by serum R is present on the surface of M7 B cells.
Discussion
A crucial point in this study is whether or not M7 carries the male Y chromosome and expresses the H-Y antigen on the cell surface. Karotype analyses of M7 cells that were Q-banded (11) and G-banded (12) were performed on air-dried chromosome preparations of 72-h stimulated lymphocyte cultures. All cells examined, in 15 metaphases, showed a normal male karotype. The cell-surface expression of the H-Y antigen on M7 cells was examined by the use of a rat anti-H-Y antiserum (13), which is cytotoxic for human male peripheral blood lymphocytes. This anti-H-Y antiserum lysed M7 cells to the same extent as other male cells, indicating a normal expression of the H-Y antigen on the surface of M7 cells.
The failure of the HLA-A2 plus H-Y-specific CTL to lyse male M7 target cells could be explained by the inability of the structurally distinct M7 HLA-A2 molecule to form a physical association with the H-Y antigen on the cell surface. However, the finding that the anti-HLA-A2 plus H-Y-specific antiserum reacted normally with the M7 targets suggests that at least some degree of HLA-A2 H-Y association exists on the surface of the M7 cells. Therefore, a structural variation in the M7 HLA-A2 molecule may have produced a loss of the restricting antigenic determinants recognized as self by normal HLA-A2-restricted H-Y-specific CTL, but has not affected the HLA-A2 H-Y structural epitope(s) recognized by the HLA-A2 plus H-Y-specific antibody. Another possible explanation for the failure of HLA-A2-restricted anti-H-Y CTL to lyse M7 target cells could be that there has been a qualitative or quantitative alteration in the expression of the cell surface membrane HLA-A2 and H-Y determinants, resulting in interference with CTL but not with antibody recognition. In this context, it should be remembered that the antibody recognizes a MHC H-Y complex on a part of the B cells (7), and the CTL, a similar complex on PHAstimulated T cells. However, the CTL were also tested against unstimulated T cells and B cell lines of the donor M7 with negative results (data not shown). Taken together, the most likely interpretation of our findings appears to be that MHC- 
